RP-HPLC method for the determination of tenofovir in pharmaceutical formulations and spiked human plasma

Analytical Letters

Volumn 41, Issue 4, 2008, Pages 561-570

  Kandagal, P B ^a   Manjunatha, D H ^a   Seetharamappa, J ^a   Kalanur, S S ^a  

^a KARNATAK UNIVERSITY   (India)

Author keywords

Human plasma; RP HPLC; Tenofovir

Indexed keywords

EID: 41549162973     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032710801910742     Document Type: Article

References (7)

1. Crovo, P.B., Deeks, S.G., Collier, A., Safrin, S., Coakley, D.F., Miller, M., Kearney, B.P., Coleman, R.L., Lamy, P.D., Kahn, J.O., McGowan, I., and Lietman, P.S. 2001. Phase I/II trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults. Antimicrob. Agents Chemother., 45: 2733-2739.
2. Cundy, K.C., Sueoka, C., Lynch, G.R., Griffin, L., Lee, W.A., and Shaw, J.P. 1998. Pharmacokinetics and bioavailability of the anti-human immunodeficiency virus nucleotide analog 9-[(R)2-(phosphonomethoxy) propyl]adenine (PMPA) in dogs. Antimicrob. Agents Chemother., 42: 687-690.
3. Jullien, V., Treluyer, J.M., and Rey, E. 2003. Determination of tenofovir in human plasma by high-performance liquid chromatography with spectrofluorimetric detection. J. Chromatogr. B, 785: 377-381.
4. Lyseng-Williamson, K.A., Reynolds, N.A., and Plosker, G.L. 2005. Tenofovir disoproxil fumarate: a review of its use in the management of HIV infection. Drugs, 65: 413-432.
5. Munoz de Benito, R.M. and Arribas Lopez, J.R. 2006. Tenofovir disoproxil fumarateemtricitabine coformulation for once-daily dual NRTI backbone. Expert Review of Anti-Infective., 4: 523-527.
6. Rezk, N.L., Crutchley, R.D., and Kashuba, A.D.M. 2005. Simultaneous quantification of emtricitabine and tenofovirin human plasma using high-performance liquid chromatography after solid phase extraction. J. Chromatogr. B, 822: 201-208.
7. Sentenac, S., Fernandez, C., Thuillier, A., Lechat, P., and Aymard, G. 2003. Sensitive determination of tenofovir in human plasma samples using reversed-phase liquid chromatography. J. Chromatogr. B, 793: 317-324.